UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 998

Sortiert nach

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)

Annals of oncology, 2006-10, Vol.17 (10), p.1546-1552

2006

Volltextzugriff (PDF)

Bortezomib Retreatment in Relapsed Multiple Myeloma – Results from a Retrospective Multicentre Survey in Germany and Switzerland

Oncology, 2010-01, Vol.79 (3-4), p.247-254

2010

Volltextzugriff (PDF)

Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27β DNA probe

Blood, 1994-02, Vol.83 (4), p.931-938

1994

Volltextzugriff (PDF)

Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma

Journal of clinical oncology, 1998-03, Vol.16 (3), p.850-858

1998

Volltextzugriff (PDF)

Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study

Annals of oncology, 2002-10, Vol.13 (10), p.1641-1649

2002

Volltextzugriff (PDF)

Cladribine (2‐CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia

British journal of haematology, 1997-11, Vol.99 (2), p.358-363

1997

Volltextzugriff (PDF)

High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias

Annals of oncology, 1994-01, Vol.5 (1), p.57-64

1994

Volltextzugriff (PDF)

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia

Annals of oncology, 1998-07, Vol.9 (7), p.721-726

1998

Volltextzugriff (PDF)

High Pressure Chemical Engineering

1, 1996

Volltextzugriff (PDF)

The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children

Bone marrow transplantation (Basingstoke), 1995, Vol.15 (1), p.25-31

1995

Volltextzugriff (PDF)

2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III–IV non-Hodgkin's lymphoma

Annals of oncology, 1996-10, Vol.7 (8), p.793-799

1996

Volltextzugriff (PDF)

Clonal analysis of a B-cell lymphoma with recurrent spontaneous remissions and evolution into chronic lymphocytic leukaemia

Annals of oncology, 1996-11, Vol.7 (9), p.953-960

1996

Volltextzugriff (PDF)

Bortezomib Retreatment in Relapsed Multiple Myeloma - Results from a Retrospective Multicenter Survey in Germany and Switzerland

Oncology, 2011-03, Vol.79 (3-4), p.247

2011

Volltextzugriff (PDF)

Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy

British journal of cancer, 1993-01, Vol.67 (1), p.163-171

1993

Volltextzugriff (PDF)

Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during a long-term follow-up in patients treated with cladribine for hairy cell leukemia

Archives of pathology & laboratory medicine (1976), 2006-03, Vol.130 (3), p.374-377

2006

Volltextzugriff (PDF)

129PD A SWISS RETROSPECTIVE LUNG CANCER SURVEY ON DOSE CHANGE AND DURATION OF TREATMENT WITH ORAL TYROSINE KINASE INHIBITORS (TKI)

Lung cancer (Amsterdam, Netherlands), 2009, Vol.64, p.S55-S55

2009

Volltextzugriff (PDF)

Phase II study with mitomycin, ifosfamide and carboplatin in inoperable non-small cell lung cancer

European journal of cancer & clinical oncology, 1991-01, Vol.27 (9), p.1106-1108

1991

Volltextzugriff (PDF)

Intensive induction and consolidation chemotherapy in a young woman with acute myeloid leukemia and severe chronic renal failure

Annals of hematology, 1996-05, Vol.72 (5), p.327-328

1996

Volltextzugriff (PDF)

Mediastinal germ cell tumour with an uncommon micropapillary architecture on histology

Annals of oncology, 1991-11, Vol.2 (10), p.771-772

1991

Volltextzugriff (PDF)

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)

Annals of oncology, 1998-07, Vol.9 (7), p.721

1998

Volltextzugriff (PDF)

Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK)

British journal of haematology, 1997-11, Vol.99 (2), p.358

1997

Volltextzugriff (PDF)

Interpretation of X-Chromosome Inactivation Patterns

Blood, 1994-10, Vol.84 (7), p.2376-2377

1994

Volltextzugriff (PDF)

Treatment of advanced metastatic melanoma -some new approaches with chemotherapy and interleukin 2 (IL-2): 115

Melanoma research, 1993-03, Vol.3 (1), p.32

1993

Volltextzugriff (PDF)

Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe [see comments]

Blood, 1994-02, Vol.83 (4), p.931-938

1994

Volltextzugriff (PDF)

Tropical air in Zurich

Schweizerische medizinische Wochenschrift, 2000-08, Vol.130 (33), p.1164

2000

Volltextzugriff (PDF)

1 – 25 von 998

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(719)
Mit Volltextzugriff
(914)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(380)
Technology
(209)
Physical Sciences
(155)
Life Sciences & Biomedicine
(125)
Physics
(122)
Engineering
(119)
Humans
(91)
Exact Sciences And Technology
(83)
Engineering, Chemical
(72)
Materials Science
(69)
Chemistry
(60)
Physics, Applied
(58)
Female
(50)
Male
(49)
Biological And Medical Sciences
(39)
Physics, Condensed Matter
(39)
Applied Sciences
(38)
Adult
(36)
Middle Aged
(36)
Materials Science, Multidisciplinary
(35)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)

Bortezomib Retreatment in Relapsed Multiple Myeloma – Results from a Retrospective Multicentre Survey in Germany and Switzerland

Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27β DNA probe

Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma

Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study

Cladribine (2‐CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia

High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia

High Pressure Chemical Engineering

The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children

2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III–IV non-Hodgkin's lymphoma

Clonal analysis of a B-cell lymphoma with recurrent spontaneous remissions and evolution into chronic lymphocytic leukaemia

Bortezomib Retreatment in Relapsed Multiple Myeloma - Results from a Retrospective Multicenter Survey in Germany and Switzerland

Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy

Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during a long-term follow-up in patients treated with cladribine for hairy cell leukemia

129PD A SWISS RETROSPECTIVE LUNG CANCER SURVEY ON DOSE CHANGE AND DURATION OF TREATMENT WITH ORAL TYROSINE KINASE INHIBITORS (TKI)

Phase II study with mitomycin, ifosfamide and carboplatin in inoperable non-small cell lung cancer

Intensive induction and consolidation chemotherapy in a young woman with acute myeloid leukemia and severe chronic renal failure

Mediastinal germ cell tumour with an uncommon micropapillary architecture on histology

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)

Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK)

Interpretation of X-Chromosome Inactivation Patterns

Treatment of advanced metastatic melanoma -some new approaches with chemotherapy and interleukin 2 (IL-2): 115

Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe [see comments]

Tropical air in Zurich

Suchergebnisse filtern